Edition:
United States

ReNeuron Group PLC (RQE.L)

RQE.L on London Stock Exchange

2.88GBp
11:27am EST
Change (% chg)

0.00p (+0.00%)
Prev Close
2.88p
Open
3.25p
Day's High
--
Day's Low
--
Volume
16,361,724
Avg. Vol
2,557,262
52-wk High
3.87p
52-wk Low
2.25p

RQE.L

Chart for RQE.L

About

ReNeuron Group plc is a clinical-stage company. The Company, through its subsidiaries, is engaged in researching and developing cell-based therapies. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells... (more)

Overall

Beta: 1.44
Market Cap(Mil.): £79.12
Shares Outstanding(Mil.): 3,164.62
Dividend: --
Yield (%): --

Financials

  RQE.L Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -0.00 -- --
ROI: -27.90 -1.09 14.95
ROE: -28.11 -2.39 16.29

Earnings vs. Estimates